documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
35 rows where docket_id = "NRC-2022-0218" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_date, posted_month, last_modified, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 2
agency_id 1
- NRC 35
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRC-2022-0218-0195 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | LTR-24-0219 Dana Smetherman, Chief Executive Officer, American College of Radiology, Letter re: SECY-24-0067 on Proposed Rule - Reporting Nuclear Medicine Injection Extravasation as Medical Events | Supporting & Related Material | 2025-02-11T00:00:00Z | 2025 | 2 | 2025-05-21T06:20:58Z | 0 | 0 | 090000648694f2b4 | ||||
| NRC-2022-0218-0196 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | 10-16-24 Letter from Simon Davies to NRC | Supporting & Related Material | 2025-02-11T00:00:00Z | 2025 | 2 | 2025-05-21T06:20:57Z | 0 | 0 | 090000648694f2b5 | ||||
| NRC-2022-0218-0199 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | 10-21-24 DG-8062 Public Comment From YSC | Supporting & Related Material | 2025-02-11T00:00:00Z | 2025 | 2 | 2025-05-21T06:20:58Z | 0 | 0 | 090000648694f2b8 | ||||
| NRC-2022-0218-0197 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | LTR-24-0227 Simon Davies, Executive Director, Teen Cancer America, Patients for Safer Nuclear Medicine Spokesperson, comments on Nuclear Regulatory Commission's Draft Regulatory Guide DG-8062 for radiopharmaceutical extravasation reporting | Supporting & Related Material | 2025-02-11T00:00:00Z | 2025 | 2 | 2025-05-21T06:20:58Z | 0 | 0 | 090000648694f2b6 | ||||
| NRC-2022-0218-0198 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Venus Gines Commenting on Draft Regulatory Guide | Supporting & Related Material | 2025-02-11T00:00:00Z | 2025 | 2 | 2025-05-21T06:20:58Z | 0 | 0 | 090000648694f2b7 | ||||
| NRC-2022-0218-0190 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | 07-10-24 Ron Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request submitted to NRC in February 2023, and the most recent NRC OIG findings | Supporting & Related Material | 2024-09-30T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:01Z | 0 | 0 | 09000064867a2e8b | ||||
| NRC-2022-0218-0191 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | 08-27-24 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: NRC's reply and the proposed rule regarding the reporting of extravasations | Supporting & Related Material | 2024-09-30T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:01Z | 0 | 0 | 09000064867a2e8d | ||||
| NRC-2022-0218-0189 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | April 11, 2023 - NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter regarding Extravasation, Abnormal Occurrence reporting, and Information Correction Requests | Supporting & Related Material | 2024-09-25T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:02Z | 0 | 0 | 0900006486786688 | ||||
| NRC-2022-0218-0188 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 28, 2023 - Response to Ronald Lattanze Appeal Letter to the NRC Information Quality Coordinator dated May 12, 2023 re: SECY-22-0043, “Petition for Rulemaking and Rulemaking Plan on Reporting Nuclear Medicine Injection Extravasations as Medical Events" | Supporting & Related Material | 2024-09-25T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:02Z | 0 | 0 | 09000064867846bb | ||||
| NRC-2022-0218-0187 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | August 8, 2024 - NRC Response to R. Lattanze July 2024 Letter | Supporting & Related Material | 2024-09-25T00:00:00Z | 2024 | 9 | 2025-05-21T06:22:02Z | 0 | 0 | 09000064867846b9 | ||||
| NRC-2022-0218-0185 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | August 7, 2024 - Letter to NRC medical staff re proposed rule and 99mTC case report | Supporting & Related Material | 2024-08-25T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 090000648667632d | ||||
| NRC-2022-0218-0184 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | April 4, 2023 - LTR-23-0081 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request Follow-up | Supporting & Related Material | 2024-08-25T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 0900006486672f5e | ||||
| NRC-2022-0218-0186 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | July 1, 2024 Email to Raymond Furstenau from Teen Cancer America and K. Williams Response Regarding Extravasations rulemaking | Supporting & Related Material | 2024-08-25T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 090000648667632e | ||||
| NRC-2022-0218-0182 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 15, 2023 - LTR-23-0157 - Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, Letter re: Extravasations, Abnormal Occurrence reporting, and Information Correction Request | Supporting & Related Material | 2024-08-23T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 0900006486672ea7 | ||||
| NRC-2022-0218-0183 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | February 15, 2024 - LTR-24-0030 Mary Ajango, Spokesperson, Patients for Safer Nuclear Medicine Coalition, Letter re: concerns about reporting requirements for extravasations ML24051A042 | Supporting & Related Material | 2024-08-23T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:12Z | 0 | 0 | 0900006486674c6a | ||||
| NRC-2022-0218-0173 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Draft for ACMUI Review - Draft Model Procedures for Evaluating and Reporting Extravasation Medical Events | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6b5 | ||||
| NRC-2022-0218-0176 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 11, 2024 - Draft Report - Subcommittee on Extravasations | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6f3 | ||||
| NRC-2022-0218-0180 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | February 16, 2023 - LTR-23-0038 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Extravasation, Abnormal Occurrence Reporting, and Information Correction Requests | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 1 | 090000648665e7ce | ||||
| NRC-2022-0218-0174 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 17, 2024 - MUI Extravasations Meeting Handout | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6b8 | ||||
| NRC-2022-0218-0175 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | August 21, 2024 - For ACMUI Review - Preliminary Extravasation Proposed Rule Package | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6bb | ||||
| NRC-2022-0218-0178 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 17, 2024 - Transcript of Meeting of the Advisory Committee on the Medical Uses of Isotopes - Pages 1 - 93 | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665ec26 | ||||
| NRC-2022-0218-0181 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | May 12, 2023 LTR-23-0129 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Abnormal Occurrence Reporting, and Information Correction Request | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 09000064866601ee | ||||
| NRC-2022-0218-0179 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | NRC Response to Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC - Letter regarding Extravasation. Abnormal Occurrence Reporting and Information Correction Requests | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665ed18 | ||||
| NRC-2022-0218-0177 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | June 17, 2024 - Final Report - Advisory Committee on Medical Uses of Isotopes (ACMUI) | Supporting & Related Material | 2024-08-22T00:00:00Z | 2024 | 8 | 2025-05-21T06:24:13Z | 0 | 0 | 090000648665e6f2 | ||||
| NRC-2022-0218-0053 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | STC-23-053 Notification of Proposed Rulemaking Fusion Energy Systems | Supporting & Related Material | 2023-07-24T00:00:00Z | 2023 | 7 | 2025-05-21T06:33:38Z | 0 | 1 | 0900006485d2a16f | ||||
| NRC-2022-0218-0045 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Reporting Nuclear Medicine Injection Extravasations as Medical Events | Proposed Rule | 2023-07-18T00:00:00Z | 2023 | 7 | 2025-05-21T06:33:43Z | 2023-15130 | 0 | 0 | 0900006485cd23b6 | |||
| NRC-2022-0218-0043 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | STC-23-033 Comment Extension Request from OAS Board | Supporting & Related Material | 2023-07-13T00:00:00Z | 2023 | 7 | 2025-05-21T06:33:51Z | 0 | 0 | 0900006485ca04ae | ||||
| NRC-2022-0218-0033 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | May 24 Extravasation Public Meeting Summary | Supporting & Related Material | 2023-06-29T00:00:00Z | 2023 | 6 | 2025-05-21T06:34:10Z | 0 | 0 | 0900006485c1b265 | ||||
| NRC-2022-0218-0032 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | May 24 Extravasation Public Meeting Transcript | Supporting & Related Material | 2023-06-29T00:00:00Z | 2023 | 6 | 2025-05-21T06:34:10Z | 0 | 0 | 0900006485c1b261 | ||||
| NRC-2022-0218-0009 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Reporting Nuclear Medicine Injection Extravasations as Medical Events; Correction | Proposed Rule | 2023-04-25T00:00:00Z | 2023 | 4 | 2023-04-25T00:00:00Z | 2025-05-21T06:35:07Z | 2023-08685 | 0 | 0 | 09000064859844f2 | ||
| NRC-2022-0218-0005 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Preliminary Proposed Rule Language | Supporting & Related Material | 2023-04-20T00:00:00Z | 2023 | 4 | 2025-05-21T06:35:17Z | 0 | 0 | 090000648596a26d | ||||
| NRC-2022-0218-0004 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Reporting Nuclear Medicine Injection Extravasations as Medical Events | Proposed Rule | 2023-04-19T00:00:00Z | 2023 | 4 | 2023-04-19T00:00:00Z | 2023-09-02T03:59:59Z | 2025-05-21T06:35:17Z | 2023-08238 | 0 | 0 | 090000648595e557 | |
| NRC-2022-0218-0003 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Mary Ajango, Spokesperson, Young Survival Coalition, Patients for Safer Nuclear Medicine Coalition Spokesperson, Letter re: NRC’s decision about extravasations | Supporting & Related Material | 2023-03-21T00:00:00Z | 2023 | 3 | 2025-05-21T06:35:43Z | 0 | 1 | 0900006485815e65 | ||||
| NRC-2022-0218-0002 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | March 11, 2024 - 12. LTR-23-0081 Ronald Lattanze, Chief Executive Officer, Lucerno Dynamics, LLC, Letter re: Information Correction Request Follow-up | Supporting & Related Material | 2023-03-21T00:00:00Z | 2023 | 3 | 2025-05-21T06:35:43Z | 0 | 1 | 0900006485815e66 | ||||
| NRC-2022-0218-0001 | NRC | Reporting Nuclear Medicine Injection Extravasations as Medical Events NRC-2022-0218 | Reporting Nuclear Medicine Injection Extravasations as Medical Events | Proposed Rule | 2022-12-30T00:00:00Z | 2022 | 12 | 2025-05-21T06:36:17Z | 2022-28356 | 0 | 0 | 0900006485568e61 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;